Persistent SARS-CoV-2 infectivity greater than 50 days in a case series of allogeneic peripheral blood stem cell transplant recipients.
Saved in:
| Title: | Persistent SARS-CoV-2 infectivity greater than 50 days in a case series of allogeneic peripheral blood stem cell transplant recipients. |
|---|---|
| Authors: | Han A; Metro Infectious Disease Consultants, 901 McClintock Drive, Suite 201, Burr Ridge, Chicago, IL 60527, United States., Rodriguez TE; Department of Medicine, Advocate Lutheran General Hospital, Advocate Aurora Health, Rosalind Franklin University of Medicine and Science, North Chicago, United States., Beck ET; Department of Microbiology, ACL Laboratories, Advocate Aurora Health, United States., Relich RF; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, United States., Udeoji DU; Department of Internal Medicine, Advocate Lutheran General Hospital, United States., Petrak R; Department of Internal Medicine, Advocate Lutheran General Hospital, United States., Chundi VV; Metro Infectious Disease Consultants, Chicago, Illinois, United States. |
| Source: | Current problems in cancer. Case reports [Curr Probl Cancer Case Rep] 2021 Mar; Vol. 3, pp. 100057. Date of Electronic Publication: 2021 Jan 16. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918231203906676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6219 (Electronic) Linking ISSN: 26666219 NLM ISO Abbreviation: Curr Probl Cancer Case Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
